PharmiWeb.com - Global Pharma News & Resources
16-Jul-2019

Medios AG gains Austrian family office as an investor

DGAP-News: Medios AG / Key word(s): Miscellaneous

16.07.2019 / 16:30
The issuer is solely responsible for the content of this announcement.


Medios AG gains Austrian family office as an investor

Berlin, 16 July 2019 - Medios AG ('Medios'), one of Germany's leading specialty pharma companies, has gained an Austrian family office as an investor. The family office, whose name is being kept confidential as per the agreement, has acquired an equity stake of 100,000 shares.

The shares forming part of this stake were provided from share options of executives and management board members. These options had been granted as part of an employee participation programme in financial year 2016.

Matthias Gärtner, CFO of Medios AG: 'We are happy to have gained an established Austrian family office as a long-term investor. This emphasises the appeal of Medios, also outside of Germany. In addition, we have again increased the company's free float through this private placement. This will further strengthen the presence of Medios in capital markets, which will also benefit our existing shareholders.'

About Medios AG
Medios AG is one of the leading Specialty Pharma companies in Germany. As a specialist for the provision of Specialty Pharma drugs to patients and GMP-certified provider of patient-specific therapies, Medios covers substantial elements of the supply chain in this field and follows the highest international quality standards. Usually, Specialty Pharma drugs are high-priced medicines for rare and/or chronic diseases. Patient-specific therapies are, for example, infusions that are compiled and produced on the basis of individual diseases and parameters like body weight and surface. It is Medios' aim to provide integrated solutions along the value chain to partners and clients, thereby ensuring an optimal pharmaceutical care for patients.

Medios AG is Germany's first publicly listed Specialty Pharma company. The share (WKN: A1MMCC, ISIN: DE000A1MMCC8) is listed in the Regulated Market of the Frankfurt Stock Exchange (General Standard).

Contact
Kirchhoff Consult AG
Nikolaus Hammerschmidt
Borselstraße 20
22765 Hamburg
Germany
Tel.: +49 40 60918618
Fax: +49 40 60918660
E-mail: nikolaus.hammerschmidt@kirchhoff.de
www.kirchhoff.de

Disclaimer
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.



16.07.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Medios AG
Friedrichstraße 113a
10117 Berlin
Germany
Phone: +49 30 232 566 - 800
Fax: +49 30 232 566 - 801
E-mail: ir@medios.ag
Internet: www.medios.ag
ISIN: DE000A1MMCC8
WKN: A1MMCC
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf
EQS News ID: 842079

 
End of News DGAP News Service

Editor Details

Last Updated: 16-Jul-2019